Nuvalent, Inc. (NUVL) financial statements (2022 and earlier)

Company profile

Business Address ONE BROADWAY, 14TH FLOOR
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments288,111
Cash and cash equivalents68,526
Short-term investments219,585
Other undisclosed current assets2,517
Total current assets:290,628
Noncurrent Assets
Other noncurrent assets3,196
Total noncurrent assets:3,196
TOTAL ASSETS:293,824
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,787
Accounts payable2,893
Accrued liabilities5,894
Total current liabilities:8,787
Noncurrent Liabilities
Total liabilities:8,787
Stockholders' equity
Stockholders' equity attributable to parent, including:285,037
Additional paid in capital363,483
Accumulated other comprehensive loss(228)
Accumulated deficit(78,223)
Other undisclosed stockholders' equity attributable to parent5
Total stockholders' equity:285,037
TOTAL LIABILITIES AND EQUITY:293,824

Income statement (P&L) ($ in thousands)

12/31/2021
Operating expenses(45,817)
Operating loss:(45,817)
Nonoperating expense(521)
Other nonoperating income114
Interest and debt expense(580)
Loss before gain (loss) on sale of properties:(46,918)
Other undisclosed net income580
Net loss available to common stockholders, diluted:(46,338)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(46,338)
Comprehensive loss:(46,338)
Other undisclosed comprehensive loss, net of tax, attributable to parent(228)
Comprehensive loss, net of tax, attributable to parent:(46,566)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: